[1]
Youseif, A.L. et al. 2026. Efficacy and Safety of Lower- versus Higher-Dose Baxdrostat in Adults with Resistant or Uncontrolled Hypertension, Including a CKD-Enriched Population: An Indirect Subgroup Comparison from Placebo-Controlled Trials — A Systematic Review and Meta-Analysis with GRADE Assessment. ASIDE Endocrinology . 1, 1 (Jun. 2026), 1–9. DOI:https://doi.org/10.71079/ASIDE.EN.06242026.